In vitro characterization of ciprofloxacin distribution in rat lung

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 20, Issue 5, 1998, Pages 369-375

  Reinoso, R F ^a   Navarro, A S ^a   Lanao, J M ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Ciprofloxacin; In vitro studies; Lungs; Rats; Subcellular fractions; Tissue distribution

Indexed keywords

CIPROFLOXACIN; NALIDIXIC ACID; OFLOXACIN; QUINOLONE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL FRACTIONATION; DATA ANALYSIS; DRUG BINDING; DRUG DISTRIBUTION; DRUG TARGETING; DRUG UPTAKE; LUNG HOMOGENATE; MALE; NONHUMAN; RAT; STATISTICAL ANALYSIS; TISSUE DISTRIBUTION;

EID: 0031830985     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.1998.20.5.485695     Document Type: Article

References (27)

1. Wolfson, J.S., Hooper. D.C. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrob Agents and Chemother 1985, 25: 319-32.
2. Chin, N-X., Neu, H.C. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria. Antimicrob Agents Chemother 1984, 25: 319-32.
3. Zeiler, H.J., Grohe, K. The in vitro and in vivo activity of ciprofloxacin. Eur J Clin Microbiol 1984, 3: 339-43.
4. Nix, D.E., DeVito, J.M. Ciprofloxacin and norfloxacin, two fluoroquinolone antimicrobials. Clin Pharm 1987, 6: 105-17.
5. Terp, D.K., Rybak, M.J. Ciprofloxacin. Drug Int Clin Pharm. 1987, 21: 568-74.
6. Bergan, T., Dalhoff, A., Rohwedder, R. Pharmacokinetics of ciprofloxacin. Infection 1988, 16(Suppl. 1): S3-S13.
7. Fass, R.J. Efficacy and safely of oral ciprofloxacin in the treatment of serious respiratory tract infections. Am J Med 1987, 82 (Suppl. 4A): 202-7.
8. Vance-Bryan, F., Guay, D.R.P., Rotschafer, J.C. Clinical pharmacokinetics of ciprofloxacin. Clin Pharmacokinet 1990, 19: 436-46.
9. Schlenkhoff, D., Dalhoff, A., Knopf, J., Opferkuch, W. Penetration of ciprofloxacin into human lung tissue following intravenous injection. Infection 1986, 14: 299-300.
10. Honeyboume, F., Wise, R., Audrews, J.M. Ciprofloxacin penetration into lungs. Lancet 1987, 8540: 1040.
11. Hopf, G., Bocker, R., Estler, C-J., Radtke, H.J., Floh, W. Concentration of ciprofloxacin in human serum, lung and pleural tissues and fluids during and after lung surgery. Infection 1988, 16: 37-8.
12. Caruso, E., Castro, J.M., Chamoles, N., Galimbert, R., Jorge, L., Rohwedder, R. Penetration of ciprofloxacin into human lung tissue after oral and i.v. dosing. J Chemother 1989, (Suppl. 4): 549-51.
13. Rohwedder, R. Tissue penetration of ciprofloxacin with special reference to the lung. In: Ciprofloxacin in Pulmonology. Fass, R.J. (Ed.). W. Zuckschwerdt Verlag: München 1990, 67-76.
14. Gleadhill, I.C., Ferguson, W.P., Lowry, R.C. Efficacy and safety of ciprofloxacin in patients with respiratory infections in comparison with amoxycillin. J Antimicrob Chemother 1986, 18 (Suppl. D): 133-8.
15. Schneck, L.W., Pritchard, F., Hayes, Jr A.H. Studies on the uptake and binding of propanolol by rat tissues. J Pharmacol Exp Ther 1977, 203: 621-9.
16. Weder, H.G., Bickel, M.R Interactions of drugs with proteins I. J Pharm Sci 1970, 59: 1505-7.
17. Weder, H.G., Bickel, M.H. Interactions of drugs with proteins II. J Pharm Sci 1970, 59: 1563-9.
18. Weder, H.G., Schildknecht, J., Kesselring, P. A new equilibrium dialyzing system. Am Lab 1971, 10: 15-21.
19. Lin, J.H., Sugiyarna, Y., Awazu, S., Hanano, M. In vitro and in vivo evaluation of the tissue-to-blood partition coefficient for physiological pharmacokinetic models. J Pharmacokinet Biopharm 1982, 10: 637-47.
20. Huang, J. Errors in estimating the unbound fraction of drugs due to the volume shift in equilibrium dialysis. j Pharm Sci 1983, 72: 1368-9.
21. Tozer, T.N., Gambertoglio, J.G., Furst, D.E., Avery, D.S., Holford, N.H.G. Volume shifts and protein binding estimates using equilibrium dialysis: application to prednisolone binding in humans. J Pharm Sci 1983, 72: 1442-6.
22. Dudley, M.N., Ericson, J., Zinner, S.H. Effect of dose on serum phannacokinetics of intravenous ciprofloxacin with identification and characterization of extravascular compartments using non compartmental and compartmental pharmacokinetic models. Antimicrob Agents Chemother 1987, 31: 1782-6.
23. Yamaoka, K., Tanigawara, Y., Nakagawa, T., Uno, T. A pharmacokinetic analysis program (MULTI) for microcomputer. J Pharm Dyn 1981, 4: 879-85.
24. Boxembaum, H.G., Riegelman, S., Elashoff, R.M. Statistical estimation in pharmacokinetics. J Pharmacokinet Biopharm 1974, 2: 123-47.
25. Yamaoka, K., Nakagawa, T., Uno, T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 1978, 6: 165-75.
26. Murphy, E.A. Analysis of variance. In: Biostatistics in Medicine. The Johns Hopkins University Press: Baltimore 1982, 137-200.
27. Potter, V.R. Tissue homogenates. In: Methods in Enzymology. Colowick, S.P., Kaplan, N.O. (Eds.). Academic Press: New York 1955, 10-5.